Randomized trial of the safety and efficacy of anti-SARS-CoV-2 mAb in the treatment of patients with nosocomial COVID-19 (CATCO-NOS).

REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche

bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases

http://www.ncbi.nlm.nih.gov/pubmed/38058498

Alain Tremblay; Ashlesha Sonpar; Conar O'Neil; Holly Hoang; John Conly; Ranjani Somayaji; Robert Fowler; Srin Murthy; Wendy Sligl

Dec 7, 2023